register

Marketing & Strategy

From pandemic evolution to future trends: Janssen reveals success behind PR campaign

Health Industry Hub | November 30, 2022 |

Marketing & Strategy: In recognising and celebrating excellence in healthcare marketing and communications in the pharmaceutical and life science industry, Health Industry Hub was the proud media partner for the PRIME Awards again this year.

Janssen was crowned the winner of the Best PR Campaign – Commercial and Corporate for the launch of Spravato (esketamine) – a novel antidepressant nasal spray for the treatment of major depressive disorder (MDD).

Janssen’s Adam Wyldeck, Head of Communications & Public Affairs and Marcelo Blanchard, Business Unit Director of Neuroscience joined Health Industry Hub to reveal the unmet clinical need behind the award-winning campaign and the key factors that made this PR campaign such a success.

The duo reflected on how PR has evolved since the start of the pandemic and why this is so relevant to the pharma industry. They discussed the shift in approaches to measuring the success of PR campaigns and the new KPIs that are shaping how we look at the ROI of these investments.

Finally, Adam and Marcelo considered what the future of PR looks like and the key trends that will be essential in supporting more impactful launches of innovative medicines and therapies in the pharma industry.

Reimagining healthcare across the entire patient journey: Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change in healthcare.

The content on Health Industry Hub is copyright protected and can only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - Pharmaceuticals

Is the government is gearing up to release the long-awaited response to The New Frontier report?

Government’s long-awaited response to The New Frontier report unveiled after two-year wait

Health Industry Hub | December 1, 2023 |

Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]

More


News & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the 'unsung heroes'

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’

Health Industry Hub | December 1, 2023 |

Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]

More


News & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn's disease in seven years

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years

Health Industry Hub | December 1, 2023 |

Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]

More


ESG

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

Health Industry Hub | November 30, 2023 |

ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]

More


This content is copyright protected. Please subscribe to gain access.